15% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
International Journal of Stroke (IJS) shared a new study on X:
”Study finds BAO recanalization during interhospital transfer for thrombectomy was associated with favorable 3-month outcome. Primary modifiable factor, yet its use remains low.”
Read the full article here.
Lately published article ”Recanalization of Basilar Artery Occlusion during Interhospital Transfer for Thrombectomy” in the International Journal of Stroke by Grace Adwane et al. sheds light on the possible opportunities with intravenous thrombolysis.
Patients with acute ischemic stroke due to basilar artery occlusion (BAO) often require transfer from non-endovascular capable centers to comprehensive stroke centers for thrombectomy.
New data show that 15% of these patients achieve recanalization during transfer, which is linked to better 3-month outcomes.
However, the use of intravenous thrombolysis (IVT) — the main modifiable factor promoting recanalization — remains underutilized at referring centers.
Expanding IVT access and exploring additional recanalization therapies at the primary stroke center level could help bridge this treatment gap and improve patient outcomes.
All the latest advancements in the field of stroke management featured in Hemostasis Today.
-
Jul 18, 2025, 12:18NBCA Hosts PEP Talk with Dr. Parks on Aging and Blood Clots
-
Jul 18, 2025, 12:14WFH Shares Powerful Patient Story on Access to Bleeding Disorders Treatment
-
Jul 18, 2025, 11:53HTRS Shines Spotlight on Faculty Powering the Future of Hemostasis and Thrombosis
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 19, 2025, 17:16Promising 85% Response: Ru-D Regimen Shows Hope for Adults with HLH
-
Jul 19, 2025, 16:16A Potential Link to Recurrent Pregnancy Loss: Monoclonal Anti-PF4 Antibodies' Role
-
Jul 19, 2025, 15:2115% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
-
Jul 18, 2025, 18:54New Issue Alert! Advances in Stroke: Vascular and Interventional Neurology 2025
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 16, 2025, 10:24Salma Ismail: Honored to Be Invited By the EHA2025 as Part of Their Lighting the Flame Program
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs